Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 106-111

  Velázquez, Ixane ^a   Plaud, Marinés ^b   Wojna, Valerie ^b,c   Skolasky, Richard ^e   Laspiur, Juliana Pérez ^b,d   Meléndez, Loyda M ^a,b,d  

^a UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^b Specialized Neuroscience Research Program in NeuroAIDS   (Puerto Rico)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d RCMI Clinical Proteomics Discovery Core Facility   (Puerto Rico)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antioxidant enzymes; Cu Zn SOD; HAART; HIV associated cognitive impairment; Women

Indexed keywords

ANTIOXIDANT; ANTIRETROVIRUS AGENT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; PROTEINASE INHIBITOR; SELENIUM GLUTATHIONE PEROXIDASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISPANIC; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED COGNITIVE IMPAIRMENT; IMMUNOPATHOGENESIS; MONOCYTE; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ADULT; AIDS DEMENTIA COMPLEX; ANALYSIS OF VARIANCE; CATALASE; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE PEROXIDASE; HISPANIC AMERICANS; HUMANS; LONGITUDINAL STUDIES; MONOCYTES; RETROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE;

EID: 58149475955     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.013     Document Type: Article

References (44)

1. Adamson D.C., McArthur J.C., Dawson T.M., and Dawson V.L. Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS. Mol. Med. 5 (1999) 98-109
2. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Esptein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., and Wojna V. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69 (2007) 1789-1799
3. Boven L.A., Gomes L., Hery C., Gray F., Verhoef J., Portergeis P., Tardieu M., and Nottet H.S.L.M. Increased peroxynitrate activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J. Immunol. 162 (1999) 4319-4327
4. Brew B.J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18 suppl 1 (2004) S75-S78
5. Brew B.J., Bhalla R.B., Morris P., Gallardo H., McArthur J.C., Schwartz M.K., and Price R.W. Cerebrospinal fluid neopterin in human immunodefiency virus type 1 infection. Ann. Neurol. 28 (1990) 556-560
6. Ciborowski P., Kadiu I., Rozek W., Smith L., Bernhardt K., Fladseth M., Ricardo-Dukelow M., and Gendelman H.E. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 363 (2007) 198-209
7. Clay C.C., Rodrigues D.S., Ho Y.S., Fallert B.A., Janatpour K., Reinhart T.A., and Esser U. Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J. Virol. 81 (2007) 12040-12048
8. Conant K., Garzino-Demo A., Nath A., McArthur J.C., Halliday W., Power C., Gallo R.C., and Major E.O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. PNAS 17 (1998) 3117-3121
9. D'Andrea G., Lizzi A.R., Venditti S., Di Francesco L., Giorgi A., Mignogna G., Oratore A., and Bozzi A. Proteins pattern alteration in AZT-treated K562 cells detected by two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteome Sci. 4 4 (2006)
10. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
11. Emerit J., Edeas M., and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58 (2004) 39-46
12. Ezzi S.A., Urushitani M., and Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 102 (2007) 170-178
13. Fisher-Smith T., and Rappaport J. Evolving paradigms in the pathogenesis of HIV-associated dementia. Expert Rev. Mol. Med. 7 (2005) 1-26
14. Fischer-Smith T., Croul S., Sverstiuk A.E., Capini C., L'Heureux D., Regulier E.G., Richardson M.W., Amini S., Morgello S., Khalili K., and Rappaport J. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. Neurovirol. 7 (2001) 528-541
15. Gonzalez E., Rovin B.H., Sen L., Cooke G., Dhanda R., Mummidi S., Kulkarni H., Bamshad M.J., Telles V., Anderson S.A., Walter E.A., Stephan K.T., Deucher M., Mangano A., Bologna R., Ahuja S.S., Dolan M.J., and Ahuja S.K. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. PNAS 99 21 (2002) 13795-13800
16. Griffin D.E. Cytokines in the brain during viral infection. Clues to HIV-associated dementia. J. Clin. Invest. 100 (1997) 2948-2951
17. Heyes M.P., Brew B.B., Martin A., Price R.W., Salazar A., Sidtis J.J., Yergey J.A., Mouradian M.M., Sadler A.E., Keilp J., Rubinow R., and Markey S.P. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29 (1991) 202-209
18. Israel N., and Gougerot-Pocidalo M.A. Oxidative stress in human immunodeficiency virus infection. CMLS. Cell. Mol. Life Sci. 53 (1997) 864-870
19. Kim W.K., Alvarez X., Fisher J., Bronfin B., Westmoreland S., McLaurin J., and Williams K. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 168 3 (2006) 822-834
20. Kolson D.L. Neuropathogenesis of central nervous system HIV-1 infection. Clin. Lab. Med. 22 (2002) 703-717
21. Laspiur J.P., Anderson E.R., Ciborowsky P., Wojna V., Rozek W., Duan F., Mayo R., Rodríguez E., Plaud-Valentín M., Rodríguez-Orengo J., Gendelman H.E., and Meléndez L.M. CSF proteomics fingerprints for HIV-associated cognitive impairment. J. Neuroimmunol. 192 (2007) 157-170
22. Leff J.A., Oppegard M.A., Curiel T.J., Brown K.S., Schooley R.T., and Repine J.E. Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. Free Radic. Biol. Med. 13 (1992) 143-149
23. Letendre S., Marquie-Beck J., Singh K.K., de Almeida S., Zimmerman J., Spector S.A., Grant I., Ellis R., and HNRC Group. The monocyte chemotactic protein-1-2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal fluid. J. Neuroimmunol. 157 (2004) 193-196
24. Lombardo M.F., Ciriolo M.R., Rotilio G., and Rossi L. Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells. CMLS. Cell. Mol. Life Sci. 60 (2003) 1733-1743
25. Luo X., Carlson K.A., Wojna W., Mayo R., Biskup T.M., Stoner J., Anderson J., Gendelman H.E., and Meléndez L.M. Macrophage proteomic fingerprinting predicts HIV-1 associated cognitive impairment. Neurology 60 (2003) 1931-1937
26. Marder K., Albert S.M., McDermott M.P., McArthur J.C., Schifitto G., Selnes O.A., Sacktor N., Stern Y., Palumbo D., Kieburtz K., Cohen B., Orme C., and Epstein L.G. Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology 60 (2003) 1467-1473
27. Marikovsky M., Ziv Vered., Nevo N., Harris-Cerruti C., and Mahler O. Cu/Zn superoxide dismutase plays important role in immune response. J. Immunol. 170 (2003) 2993-3001
28. Meléndez L.M., Mayo-Santana R., Luciano C., and Wojna V. Ethnicity and Neuro-AIDS conditions in the HAART Era. In: Goodkin K., Shapshak P., and Verma A. (Eds). Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment (2008), ASM, Washington, DC
29. Mollace V., Nottet H.S.L.M., Clayette P., Turco M.C., Muscoli C., Salvemini D., and Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24 (2001) 411-416
30. Monteiro de Almeida S., Letendre S., Zimmerman J., Lazzaretto D., Mc Cuthcan A., and Ellis R. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. J. Neuroimmunol. 169 (2005) 144-152
31. Nath A. Pathobiology of human immunodeficiency virus dementia. Semin. Neurol. 19 (1999) 113-127
32. Ogunro P.S., Ogungbamigbe T.O., Elemie P.O., Egbewale B.E., and Adewole T.A. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression. Niger. Postgrad. Med. J. 13 (2006) 1-5
33. Price T.O., Ercal N., Nakaoke R., and Banks W.A. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045 (2005) 57-63
34. Price R.W., Epstein L.G., Becker J.T., Cinque P., Gisslen M., Pulliam L., and McArthur J.C. Biomarkers of HIV-1 CNS infection and injury. Neurology 69 (2007) 1781-1788
35. Pulliam L., Gascon R., Stubblebine M., McGuire D., and McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet 349 (1997) 692-695
36. Sacktor N., Skolasky R.L., Tarwater P.M., McArthur J.C., Selnes O.A., Becker J., Cohen B., Visscher B., Miller E.N., and Multicenter AIDS Cohort Study (MACS). Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 26 (2003) 567-569
37. Sacktor N., Haughey N., Cutler R., Tamara A., Turchan J., Pardo C., Vargas D., and Nath A. Novel markers of oxidative stress in actively progressive HIV dementia. J. Neuroimmunol. 157 (2004) 176-184
38. Sevigny J.J., Albert S.M., McDermott M.P., McArthur J.C., Sacktor N., Conant K., Schifitto G., Selnes O.A., Stern Y., McClernon D.R., Palumbo D., Kieburtz K., Riggs G., Cohen B., Epstein L.G., and Marder K. Evaluation of HIVRNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63 (2004) 2084-2090
39. Song H.Y., Ju S.M., Lee J.A., Kwon H., Eum W.S., Jang S.H., Choi S.Y., and Park J. Suppression of HIV-1 Tat-induced monocyte adhesiveness by a cell-permeable superoxide dismutase in astrocytes. Exp. Mol. Med. 39 (2007) 778-786
40. Treitinger A., Spada C., Verdi J.C., Miranda A.F., Oliveira O.V., Silveira M.V., Moriel P., and Abdalla D.S. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur. J. Clin. Invest. 30 (2000) 454-459
41. Williams K.C., and Hickey W.F. Central nervous system damage, monocytes and macrophages and neurological disorders in AIDS. Annu. Rev. Neurosci. 25 (2002) 537-562
42. Williams K.C., Corey S., Westmoreland S.V., Pauley D., Knight H., De Bakker C., Alvarez X., and Lackner A.A. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193 (2001) 905-915
43. Wojna V., Skolasky R.L., Hechevarría R., Mayo R., Selnes O., MacArthur J.C., Meléndez L.M., Maldonado E., Zorrilla C.D., García H., Kraiselburd E., and Nath A. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J. NeuroVirol. 12 (2006) 356-364
44. Yano S., Yano N., Rodriguez N., Baek J.H., Que X., Yamamura Y., and Kim S.J. Suppression of intracellular hydrogen peroxide generation and catalase levels in CD8+ T-lymphocytes from HIV+ individuals. Free Radic. Biol. Med. 24 (1998) 349-359